AbbVie (ABBV) Reports Positive Phase 3 Skyrizi Trial Results for Crohn's Disease

AbbVie (ABBV) Reports Positive Phase 3 Skyrizi Trial Results for Crohn's Disease

AbbVie (ABBV) Reports Positive Phase 3 Skyrizi Trial Results for Crohn's Disease

话题：#AbbVie (ABBV) Reports Positive Phase 3

墨子AI